Preliminary results of a accelerated dose escalation phase I trial with a novel anthracycline derivative (RTA-744) in patients with primary brain tumors

被引:0
|
作者
Conrad, C. A.
Madden, T.
Meyer, C.
Preibe, W.
Baud, C.
Fokt, I.
Gilbert, M.
Groves, M.
Levin, V.
Yung, W. K. A.
机构
[1] MD Anderson Canc Ctr, Houston, TX USA
[2] Reata Pharmaceut Inc, Dallas, TX USA
来源
EJC SUPPLEMENTS | 2006年 / 4卷 / 12期
关键词
D O I
10.1016/S1359-6349(06)70135-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
129
引用
收藏
页码:42 / 42
页数:1
相关论文
共 50 条
  • [21] Specific active immunotherapy with a VEGF vaccine in patients with advanced solid tumors. Results of the CENTAURO antigen dose escalation phase I clinical trial
    Gavilondo, J. V.
    Hernandez-Bernal, F.
    Ayala-Avila, M.
    de la Torre, A. V.
    de la Torre, J.
    Morera-Diaz, Y.
    Bequet-Romero, M.
    Sanchez, J.
    Valenzuela, C. M.
    Martin, Y.
    Selman-Housein, K. -H.
    Garabito, A.
    Lazo, O. C.
    VACCINE, 2014, 32 (19) : 2241 - 2250
  • [22] Phase I dose escalation clinical trial of phenylbutyrate sodium administered twice daily to patients with advanced solid tumors
    Camacho, Luis H.
    Olson, Jon
    Tong, William P.
    Young, Charles W.
    Spriggs, David R.
    Malkin, Mark G.
    INVESTIGATIONAL NEW DRUGS, 2007, 25 (02) : 131 - 138
  • [23] Phase I dose escalation clinical trial of phenylbutyrate sodium administered twice daily to patients with advanced solid tumors
    Luis H. Camacho
    Jon Olson
    William P. Tong
    Charles W. Young
    David R. Spriggs
    Mark G. Malkin
    Investigational New Drugs, 2007, 25 : 131 - 138
  • [24] A Phase I, Dose-Escalation Trial of Pazopanib in Combination with Cisplatin in Patients with Advanced Solid Tumors: A UNICANCER Study
    Véronique Diéras
    Thomas Bachelot
    Mario Campone
    Nicolas Isambert
    Florence Joly
    Christophe Le Tourneau
    Philippe Cassier
    Emmanuelle Bompas
    Pierre Fumoleau
    Sabine Noal
    Christine Orsini
    Marta Jimenez
    Diane Charlotte Imbs
    Etienne Chatelut
    Oncology and Therapy, 2016, 4 (2) : 211 - 223
  • [25] A Phase I, Dose-Escalation Trial of Pazopanib in Combination with Cisplatin in Patients with Advanced Solid Tumors: A UNICANCER Study
    Dieras, Veronique
    Bachelot, Thomas
    Campone, Mario
    Isambert, Nicolas
    Joly, Florence
    Le Tourneau, Christophe
    Cassier, Philippe
    Bompas, Emmanuelle
    Fumoleau, Pierre
    Noal, Sabine
    Orsini, Christine
    Jimenez, Marta
    Imbs, Diane Charlotte
    Chatelut, Etienne
    ONCOLOGY AND THERAPY, 2016, 4 (02) : 211 - 223
  • [26] Phase I dose escalation clinical trial of stereotactic body radiation therapy (SBRT) for locoregional recurrences of ovarian cancer: Dose escalation and preliminary outcomes and quality of life results
    Robin, T. P.
    Smith, D. E.
    Diamond, J. R.
    Lefkowits, C.
    Corr, B. R.
    Guntupalli, S. R.
    Behbakht, K.
    Fisher, C. M.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 150 - 151
  • [27] Interim results of a phase I trial with a novel orally administered synthetic triterpenoid RTA 402 (CDDO-Me) in patients with solid tumors and lymphoid malignancies
    Dezube, B. J.
    Kurzrock, R.
    Eder, J. P.
    Supko, J. G.
    Meyer, C. J.
    Camacho, L. H.
    Andreeff, M.
    Konopleva, M.
    Lescale-Matys, L.
    Hong, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [28] GO-8: Preliminary Results of a Phase I/II Dose Escalation Trial of Gene Therapy for Haemophilia a Using a Novel Human Factor VIII Variant
    Nathwani, Amit C.
    Tuddenham, Edward
    Chowdary, Pratima
    McIntosh, Jenny
    Lee, Doyoung
    Rosales, Cecilia
    Phillips, Mark
    Pie, Jun
    Zhou Junfang
    Meagher, Michael M.
    Reiss, Ulrike
    Davidoff, Andrew M.
    Morton, Chris L.
    Riddell, Anne
    BLOOD, 2018, 132
  • [29] INTERSTITIAL THERMORADIOTHERAPY OF BRAIN-TUMORS - PRELIMINARY-RESULTS OF A PHASE-I CLINICAL-TRIAL
    STEA, B
    CETAS, TC
    CASSADY, JR
    GUTHKELCH, AN
    IACONO, R
    LULU, B
    LUTZ, W
    OBBENS, E
    ROSSMAN, K
    SEEGER, J
    SHETTER, A
    SHIMM, DS
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1990, 19 (06): : 1463 - 1471
  • [30] Phase I study of DFP-11207, a novel chemotherapeutic agent, in patients with solid tumors by reasonable dose escalation
    Ajani, Jaffer A.
    Eng, Cathy
    Javle, Milind
    Hernandez, Katrina
    Anderson, Barry D.
    Zhang, Chun
    Iizuka, Kenzo
    ANNALS OF ONCOLOGY, 2016, 27